GALAPAGOS NV-SPON ADR (GLPG:NASDAQ)
$28.4 -0.16 (-0.5602%)
Analysed GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) News Sources
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
04-04-2026
yahoo.com
Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials
31-03-2026
marketbeat.com
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration
31-03-2026
yahoo.com
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
31-03-2026
yahoo.com
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline
27-03-2026
yahoo.com
Galapagos Announces Nomination of Gino Santini to its Board of Directors
26-03-2026
yahoo.com
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings
26-03-2026
yahoo.com
Sector Update: Health Care Stocks Advance Late Afternoon
24-03-2026
yahoo.com
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
24-03-2026
yahoo.com
Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains.
24-03-2026
yahoo.com
What is the current price of GALAPAGOS NV-SPON ADR (GLPG:NASDAQ)?
The current price of GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) is $28.4.
GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) since the previous trading day is $-0.16.
GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) since the previous trading day is -0.5602%.
What is the most recent average sentiment score for GALAPAGOS NV-SPON ADR (GLPG:NASDAQ)?
The most recent average sentiment score for GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for GALAPAGOS NV-SPON ADR (GLPG:NASDAQ)?
The most recent sentiment for GALAPAGOS NV-SPON ADR (GLPG:NASDAQ) is .
SEC-8K** Filing Available For GALAPAGOS NV-SPON ADR (GLPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.